World's Best Scientists 2026 revealed!
Gordon J. Freeman

Gordon J. Freeman

Award Badge
Best Scientists
2025
Award Badge
Immunology
USA
2026

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Best Scientists 196 341 320 226 209 633 162394
Immunology 201 11 11 6 6 618 173278
Medicine 201 178 162 118 107 620 173535

Gordon J. Freeman publications per year

The chart shows the history of publications by Gordon J. Freeman between 1979 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Gordon J. Freeman published across 47 years, from 1979 to 2025, averaging 24.3 papers a year. Output peaked at 429 publications in 2023. 56 of the 1,144 publications appeared in the last two years.

No. of publications
100 200 300 400
Bar chart. Horizontal axis: year, 1979 to 2025. Vertical axis: number of publications, 0 to 429. Peak 429 publications in 2023. 1979: 1 publication 1980: 0 publications 1981: 1 publication 1982: 0 publications 1983: 1 publication 1984: 0 publications 1985: 1 publication 1986: 1 publication 1987: 2 publications 1988: 2 publications 1989: 10 publications 1990: 2 publications 1991: 7 publications 1992: 9 publications 1993: 13 publications 1994: 13 publications 1995: 17 publications 1996: 14 publications 1997: 13 publications 1998: 10 publications 1999: 9 publications 2000: 11 publications 2001: 9 publications 2002: 14 publications 2003: 12 publications 2004: 10 publications 2005: 10 publications 2006: 12 publications 2007: 25 publications 2008: 26 publications 2009: 19 publications 2010: 27 publications 2011: 18 publications 2012: 12 publications 2013: 29 publications 2014: 29 publications 2015: 40 publications 2016: 49 publications 2017: 38 publications 2018: 35 publications 2019: 24 publications 2020: 28 publications 2021: 29 publications 2022: 27 publications 2023: 429 publications 2024: 39 publications 2025: 17 publications
1979 2025

1,144 publications in total across all disciplines

View publications per year as a table
Gordon J. Freeman: publications per year, 1979 to 2025
Year Publications
1979 1
1980 0
1981 1
1982 0
1983 1
1984 0
1985 1
1986 1
1987 2
1988 2
1989 10
1990 2
1991 7
1992 9
1993 13
1994 13
1995 17
1996 14
1997 13
1998 10
1999 9
2000 11
2001 9
2002 14
2003 12
2004 10
2005 10
2006 12
2007 25
2008 26
2009 19
2010 27
2011 18
2012 12
2013 29
2014 29
2015 40
2016 49
2017 38
2018 35
2019 24
2020 28
2021 29
2022 27
2023 429
2024 39
2025 17
Total 1,144
Download as CSV

Gordon J. Freeman publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Gordon J. Freeman sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 612–621 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 618 publications — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13 618
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Gordon J. Freeman D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Gordon J. Freeman sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 157+ D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 201 D-Index — 100th percentile

100% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96 201
Download as CSV

Research.com Recognitions

  • 2026 - Research.com Immunology in United States Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Immunology in United States Leader Award
  • 2020 - Fellow, National Academy of Inventors
  • 2017 - Warren Alpert Foundation Prize For their collective contributions to the pre-clinical foundation and development of immune checkpoint blockade, a novel form of cancer therapy that has transformed the landscape of cancer treatment.

Overview

Gordon J. Freeman is affiliated with Harvard University in the United States. Their research primarily focuses on the fields of medicine and immunology and microbiology, with significant contributions in immunology, oncology, and molecular biology. Their work also intersects areas such as pulmonary and respiratory medicine and cancer research.

The scientist's main research topics include cancer immunotherapy and biomarkers, immune cell function and interaction, immunotherapy and immune responses, CAR-T cell therapy research, immune cells in cancer, T-cell and B-cell immunology, and renal cell carcinoma treatment.

Gordon J. Freeman has contributed extensively to several publication venues, most notably:

  • Cancer Research
  • Regular and Young Investigator Award Abstracts
  • Clinical Cancer Research
  • Cancer Immunology Research
  • Nature

Frequent coauthors collaborating with Freeman include:

  • Arlene H. Sharpe
  • Toni K. Choueiri
  • Sabina Signoretti
  • David F. McDermott
  • Catherine J. Wu

Selected recent papers authored or coauthored by Freeman are as follows:

  • Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma, 2020, Nature Medicine
  • The importance of exosomal PDL1 in tumour immune evasion, 2020, Nature Reviews Immunology
  • Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis, 2021, Cell
  • Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy, 2020, Nature Cell Biology
  • Tumor cells dictate anti-tumor immune responses by altering pyruvate utilization and succinate signaling in CD8+ T cells, 2022, Cell Metabolism

Freeman's contributions have been recognized with awards such as the Fellow of the National Academy of Inventors in 2020 and the Warren Alpert Foundation Prize in 2017, awarded for collective contributions to the development of immune checkpoint blockade as a cancer therapy.

Best Publications

  • PD-1 and its ligands in tolerance and immunity

    Mary E. Keir;Manish J. Butte;Gordon J. Freeman;Arlene H. Sharpe

  • Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.

    Gordon J. Freeman;Andrew J. Long;Yoshiko Iwai;Karen Bourque

  • Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

    Peng Jiang;Shengqing Gu;Deng Pan;Jingxin Fu

  • Restoring function in exhausted CD8 T cells during chronic viral infection.

    Daniel L. Barber;E. John Wherry;David Masopust;Baogong Zhu

  • PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

    Stephen M. Ansell;Alexander M. Lesokhin;Alexander M. Lesokhin;Ivan Borrello;Ahmad Halwani

  • PD-L2 is a second ligand for PD-1 and inhibits T cell activation

    Yvette Latchman;Clive R. Wood;Tatyana Chernova;Divya Chaudhary

  • PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

    Cheryl L Day;Daniel E Kaufmann;Photini Kiepiela;Julia A Brown

  • THE B7 FAMILY REVISITED

    Rebecca J. Greenwald;Gordon J. Freeman;Arlene H. Sharpe

  • CTLA-4 can function as a negative regulator of T cell activation

    Theresa L. Walunas;Deborah J. Lenschow;Christina Y. Bakker;Peter S. Linsley

  • CD4+CD25high Regulatory Cells in Human Peripheral Blood

    Clare Baecher-Allan;Julia A. Brown;Gordon J. Freeman;David A. Hafler

  • The B7–CD28 superfamily

    Arlene H Sharpe;Gordon J Freeman

  • Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection

    Shawn D Blackburn;Haina Shin;W Nicholas Haining;W Nicholas Haining;Tao Zou

  • PD-L1 regulates the development, maintenance, and function of induced regulatory T cells

    Loise Marie Francisco;Victor H. Salinas;Keturah Elise Brown;Vijay K. Vanguri;Vijay K. Vanguri

  • Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

    Matthew M. Gubin;Xiuli Zhang;Heiko Schuster;Etienne Caron

  • Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses

    Manish J. Butte;Mary E. Keir;Theresa B. Phamduy;Arlene H. Sharpe

  • Defining CD8 + T cells that provide the proliferative burst after PD-1 therapy

    Se Jin Im;Masao Hashimoto;Michael Y Gerner;Michael Y Gerner;Junghwa Lee

  • Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease

    Laurent Monney;Catherine A. Sabatos;Jason L. Gaglia;Akemi Ryu

  • The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection

    Arlene H Sharpe;E John Wherry;Rafi Ahmed;Gordon J Freeman

  • Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints.

    Shohei Koyama;Esra A. Akbay;Yvonne Y. Li;Grit S. Herter-Sprie

  • Combination cancer immunotherapy and new immunomodulatory targets.

    Kathleen M. Mahoney;Paul D. Rennert;Gordon J. Freeman

  • Tissue expression of PD-L1 mediates peripheral T cell tolerance

    Mary E. Keir;Spencer C. Liang;Indira Guleria;Yvette E. Latchman

Frequent Co-Authors

Arlene H. Sharpe
Arlene H. Sharpe Harvard University
Lee M. Nadler
Lee M. Nadler Harvard University
Vassiliki A. Boussiotis
Vassiliki A. Boussiotis Beth Israel Deaconess Medical Center
Scott J. Rodig
Scott J. Rodig Harvard University
Rosemarie H. DeKruyff
Rosemarie H. DeKruyff Stanford University
Rafi Ahmed
Rafi Ahmed Emory University
Sabina Signoretti
Sabina Signoretti Brigham and Women's Hospital
John G. Gribben
John G. Gribben Queen Mary University of London
Dale T. Umetsu
Dale T. Umetsu Stanford University
F. Stephen Hodi
F. Stephen Hodi Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology often leads students to explore complementary healthcare fields, including advanced nursing roles. For those interested in transitioning into specialized nursing, programs like cheapest psych np programs offer cost-effective pathways to become psychiatric nurse practitioners.

For nurses aiming to elevate their qualifications, understanding the financial outlook is crucial. Insights into the doctor of nursing practice salary by state help guide career decisions, balancing educational investments with potential earnings.

Specialization is key in nursing, and many professionals look to advanced acute care roles. Programs designed to support this transition are well-explained in resources outlining acnp programs, enabling family nurse practitioners to become Acute Care Nurse Practitioners.

Additionally, accelerated pathways like accelerated rn to np programs make it possible for registered nurses to fast-track their journey toward becoming nurse practitioners, complementing their background in immunology and healthcare.

Best Scientists Citing Gordon J. Freeman

Trending Scientists